VAM
AXDX

Visium Asset Management’s Accelerate Diagnostics AXDX Stock Holding History

Visium Asset Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-15,000
Closed -$2.16M – 357
2016
Q1 		$2.16M Hold
15,000
– – 0.04% 383
2015
Q4 		$3.22M Buy
+15,000
New +$2.74M 0.05% 350

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Visium Asset Management's AXDX Position: Q2 2016 in Review

Visium Asset Management sold out of Accelerate Diagnostics (AXDX) in Q2 2016, closing a stake of 15,000 shares — an estimated $2.16M sold.

Visium Asset Management first reported a position in AXDX in Q4 2015 and held it in 2 quarters. The position peaked at $3.22M in Q4 2015. 95 funds tracked by Wall St. Rank hold AXDX as of Q2 2016.

  • Visium Asset Management reported no remaining Accelerate Diagnostics position as of Q2 2016 after selling out during the quarter.
  • Visium Asset Management sold 15,000 Accelerate Diagnostics shares in Q2 2016, an estimated $2.16M.
  • Visium Asset Management first reported a position in Accelerate Diagnostics in Q4 2015 and held it in 2 quarters.
  • Visium Asset Management's Accelerate Diagnostics position peaked at $3.22M in Q4 2015.
  • 95 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.